The Medical Analysis Department, Faculty of Applied Science at Tishk International University (TIU), participated in the MEDICO Health Exhibition 2026, held from 11 to 14 August 2026 at the Erbil International Fair.
The exhibition brought together hospitals, diagnostic laboratories, healthcare providers, biotechnology companies, pharmaceutical companies, and medical and laboratory suppliers. It provided an excellent platform for the Medical Analysis Department to present its laboratory capabilities, exchange knowledge with healthcare and industry professionals, establish professional connections, and explore potential areas of collaboration.
During the exhibition, the Medical Analysis Department showcased its laboratory facilities and services for education and scientific research, with particular emphasis on the Molecular Biology Laboratory Unit. The team introduced visitors to the laboratory’s advanced infrastructure and its applications in molecular biology, genetics, biomedical research, and student practical training.
One of the key technologies highlighted during the exhibition was droplet digital PCR (ddPCR), an advanced molecular technology that enables highly precise and sensitive detection and quantification of specific genomic DNA and cDNA targets. In addition to ddPCR, the Department presented its capabilities in real-time PCR (qPCR), conventional PCR, nucleic acid extraction, gel electrophoresis, and other molecular biology techniques. These facilities support undergraduate education, student research projects, postgraduate research, and collaborative scientific studies.
The Department also presented its broader laboratory capabilities in areas such as clinical biochemistry, hematology, microbiology, molecular biology, and genetics. These laboratories provide an important environment for hands-on education, practical skills development, scientific research, and the application of modern laboratory technologies.
Throughout the exhibition, the Medical Analysis Department team met with representatives from several medical, diagnostic, biotechnology, pharmaceutical, and laboratory companies. In particular, meetings were held with Altaqaniat Alhayatiah Company and BioLab to discuss potential areas of future collaboration, including student training, laboratory activities, biotechnology applications, technical support, research projects, and access to advanced laboratory technologies and materials.
The Department’s participation was supervised and supported by Dr. Tola Faraj, Vice Dean of the Faculty of Applied Science; Dr. Sami Mamand, Head of the Medical Analysis Department; and Mr. Soran Kayfi, Coordinator, who worked closely with the Department’s research assistants and students to introduce visitors to the Department’s academic programs, research activities, laboratory facilities, and technological capabilities.
Overall, participation in MEDICO Health Exhibition 2026 provided a valuable opportunity for the Medical Analysis Department to showcase its educational and research capabilities, highlight its advanced laboratory infrastructure, discover emerging healthcare and biotechnology technologies, strengthen connections with industry, and explore new opportunities for future collaboration.
